Alger Health Sciences Fund Class A (AHSAX)
| Fund Assets | 65.65M |
| Expense Ratio | 1.18% |
| Min. Investment | $1,000 |
| Turnover | 289.28% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 22.02 |
| YTD Return | -3.38% |
| 1-Year Return | 18.44% |
| 5-Year Return | -13.79% |
| 52-Week Low | 17.23 |
| 52-Week High | 23.67 |
| Beta (5Y) | 0.67 |
| Holdings | 53 |
| Inception Date | May 1, 2002 |
About AHSAX
Alger Health Sciences Fund Class A is a mutual fund focused on delivering long-term capital appreciation by investing primarily in the health sciences sector. The fund typically allocates at least 80% of its net assets to equity securities of companies operating within healthcare, biotechnology, pharmaceuticals, medical technology, and related industries. Its investment portfolio is characterized by a concentration in large-cap stocks with a blend of growth and value styles, targeting leading health sector firms as well as innovative smaller companies. Key holdings often include industry leaders in healthcare services, medical devices, and biotechnology, reflecting the fund's commitment to broad exposure across the evolving healthcare landscape. This sector-specific focus enables the fund to capture trends in medical advancement, demographic shifts, and regulatory changes that shape the industry’s growth. Alger Health Sciences Fund Class A plays a significant role for investors seeking targeted exposure to the health sciences sector within a diversified mutual fund structure, offering professional management and research-driven selection in a vital segment of the global economy.
Performance
AHSAX had a total return of 18.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.40%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.63% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
41.20% of assets| Name | Symbol | Weight |
|---|---|---|
| Forte Biosciences, Inc. | FBRX | 5.56% |
| Eli Lilly and Company | LLY | 5.03% |
| Cardinal Health, Inc. | CAH | 4.24% |
| Teva Pharmaceutical Industries Limited | TEVA | 4.23% |
| Impulse Dynamics Ireland Series F-3 | n/a | 4.21% |
| Biogen Inc. | BIIB | 4.14% |
| AstraZeneca PLC | AZN | 3.67% |
| AbbVie Inc. | ABBV | 3.59% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 3.31% |
| CVS Health Corporation | CVS | 3.23% |